These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2842239)

  • 1. Low-molecular-weight heparin (fraxiparine) to prevent deep vein thrombosis in patients undergoing orthopedic surgery: a clinical report of two regimens.
    Drouet JC; Bernard JM; Bourreli B; Gunst JP
    Haemostasis; 1988; 18(2):135-6. PubMed ID: 2842239
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylaxis of postoperative deep vein thrombosis in general surgery: experiences with Fragmin.
    Bergqvist D
    Acta Chir Scand Suppl; 1988; 543():87-9. PubMed ID: 2847463
    [No Abstract]   [Full Text] [Related]  

  • 3. Low molecular weight heparins: deep vein thrombosis prophylaxis in elective hip surgery and thrombotic stroke.
    Turpie AG
    Acta Chir Scand Suppl; 1988; 543():85-6. PubMed ID: 2847462
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention and therapy of postoperative thrombosis and embolism.
    Röggla M; Wagner A; Malzer R; Gamper G; Janata K; Röggla G
    Acta Anaesthesiol Scand Suppl; 1997; 111():217-9. PubMed ID: 9421020
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of postoperative deep vein thrombosis by one daily injection of low molecular weight heparin and dihydroergotamine.
    Baumgartner A; Jacot N; Moser G; Krähenbühl B
    Vasa; 1989; 18(2):152-6. PubMed ID: 2545054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-molecular-weight heparin vs. warfarin for prophylaxis against deep-vein thrombosis.
    Hirsh J
    N Engl J Med; 1994 Mar; 330(12):862-3. PubMed ID: 8114845
    [No Abstract]   [Full Text] [Related]  

  • 7. Postoperative deep venous thrombosis (DVT) and low-molecular weight heparin (LMWH) type and dosage.
    Wicky J; Couson F; Ambrosetti P; Didier D; Rohner A; Bounameaux H
    Thromb Haemost; 1993 Apr; 69(4):402-3. PubMed ID: 8388582
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of postoperative deep vein thrombosis of the lower limbs].
    Baeshko AA; Sysov AV; Rolevich AI
    Klin Khir; 1998; (2):38-41. PubMed ID: 9615084
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine.
    Haas S; Stemberger A; Fritsche HM; Welzel D; Wolf H; Lechner F; Blümel G
    Arzneimittelforschung; 1987 Jul; 37(7):839-43. PubMed ID: 2823840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight heparin: laboratory properties and clinical evaluation. A review.
    Hirsh J; Levine MN
    Eur J Surg Suppl; 1994; (571):9-22. PubMed ID: 7519092
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of enoxaparine in preventing deep venous thrombosis following total hip prosthesis. Randomized multicenter prospective trial].
    Planes A; Vochelle N; Mazas F; Mansat C; Zucman J; Landais A; Pascariello JC; Weil D; Butel J
    Rev Chir Orthop Reparatrice Appar Mot; 1988; 74 Suppl 2():215-8. PubMed ID: 2852830
    [No Abstract]   [Full Text] [Related]  

  • 12. [Low molecular weight heparin: favorable effect profile for prevention and therapy of venous thrombosis].
    Marbet GA
    Ther Umsch; 1992 Dec; 49(12):843-9. PubMed ID: 1336627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight heparin for the prevention of deep vein thrombosis following orthopedic surgery.
    Lassen MR; Borris LC
    Curr Opin Pulm Med; 1996 Jul; 2(4):300-4. PubMed ID: 9363156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of a very low molecular weight heparin fragment (CY 222) compared to standard heparin in patients with deep venous thrombosis. A randomized study].
    Faivre R; Neuhart E; Kieffer Y; Bassand JP; Maurat JP
    J Mal Vasc; 1987; 12 Suppl B():145-6. PubMed ID: 2834488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of thrombosis in minimally invasive surgery].
    Harenberg J
    Zentralbl Chir; 1994; 119(6):447-8. PubMed ID: 8091883
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-benefit analysis of prophylaxis against deep vein thrombosis in surgery.
    Hauch O; Khattar SC; Jørgensen LN
    Semin Thromb Hemost; 1991; 17 Suppl 3():280-3. PubMed ID: 1661436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized double-blind study between a low molecular weight heparin Kabi 2165 and standard heparin in the prevention of deep vein thrombosis in general surgery. A French multicenter trial.
    Caen JP
    Thromb Haemost; 1988 Apr; 59(2):216-20. PubMed ID: 2838923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of low molecular weight heparin in the prevention of postoperative deep venous thrombosis. Our experience in 88 cases].
    Verardi S; Cortese F; Baroni B; Boffo V; Casciani CU
    G Chir; 1989 Nov; 10(11):674-8. PubMed ID: 2562010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydroergotamine-heparin to prevent postoperative deep vein thrombosis.
    Med Lett Drugs Ther; 1985 May; 27(688):45-6. PubMed ID: 3889570
    [No Abstract]   [Full Text] [Related]  

  • 20. [Improved postoperative prevention of thrombosis in trauma surgery by dose adjusted low molecular weight heparin based on TAT and D-dimer values].
    Hansen M; Mayer A; Peetz D; Hafner G; Prellwitz W; Rommens PM
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1213-7. PubMed ID: 9931839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.